Transgenic mice expressing PrP only in astrocytes succumb to TSE infection, demonstrating that the expression of PrPC in astrocytes is sufficient to elicit neurodegeneration and a clinical TSE disease [99]. The gene discussed is PRNP; the disease is human prion disease.